NeuroSense Therapeutics Ltd. (NRSN)

Sector
Healthcare
Industry
Biotechnology
Last price
$3.49
As of

Kresmion compiles this page from NRSN's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

NeuroSense Therapeutics Ltd. (NRSN): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-10-13.

As of . Source: SEC EDGAR filings for NRSN. Method and limitations.

COMPANY DOSSIER

See the full NRSN dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for NRSN on one page. Preview it with sample data, then open it live with a free account.

Preview the NRSN dossier

Active signals for NRSN

FREE, NO ACCOUNT

Every signal on NRSN, as it fires

You are seeing 5 of 7 signals recorded on NRSN since 2026-06-10.

The five above landed across 3 days. The other 2 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.

Recent SEC filings, NRSN

Related tickers

Follow NRSN on a live board

Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to NRSN for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the NRSN dossier
Share

The NRSN intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.